Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-020744
Filing Date
2020-03-23
Accepted
2020-03-23 19:12:29
Documents
1
Period of Report
2019-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4132
  Complete submission text file 0001209191-20-020744.txt   5639
Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address
Levine James E. (Reporting) CIK: 0001463151 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36912 | Film No.: 20736196

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)